Skip to main content
Article
Resveratrol-induced apoptosis is enhanced by inhibition of autophagy in esophageal squamous cell carcinoma
Cancer letters
  • Qishan Tang
  • Guanwu Li
  • Xiaoning Wei
  • Jun Zhang
  • Jenfu Chiu
  • Don Hasenmayer
  • Dianzheng Zhang, Philadelphia College of Osteopathic Medicine
  • Hao Zhang
Document Type
Article
Publication Date
1-1-2013
Disciplines
Abstract

The anti-cancer activity of resveratrol in human esophageal squamous cell carcinoma (ESCC) was investigated focusing on the role of autophagy and its effects on apoptotic cell death. We demonstrated that resveratrol inhibits ESCC cell growth in a dose-dependent manner by inducing cell cycle arrest at the sub-G1 phase and resulting in subsequent apoptosis. Mechanistically, resveratrol-induced autophagy in the ESCC cells is AMPK/mTOR pathway independent. Since both pharmacological and genetic inhibition of autophagy enhanced the resveratrol-induced cytotoxicity to the ESCC cells, this provided a novel strategy in potentiating the anti-cancer effects of resveratrol and other chemotherapeutic reagents in ESCC cancer treatment. © 2013 Elsevier Ireland Ltd.

Comments

This article was published in Cancer letters, Volume 336, Issue 2, Pages 325-337.

The published version is available at http://dx.doi.org/10.1016/j.canlet.2013.03.023.

Copyright © 2013Elsevier.

Citation Information
Qishan Tang, Guanwu Li, Xiaoning Wei, Jun Zhang, et al.. "Resveratrol-induced apoptosis is enhanced by inhibition of autophagy in esophageal squamous cell carcinoma" Cancer letters Vol. 336 Iss. 2 (2013) p. 325 - 337
Available at: http://works.bepress.com/dianzheng_zhang/19/